From his piece:
Hepatitis C is a scourge that is the leading cause for liver transplantation infecting close to 4 million Americans and over 180 million individuals globally. The historical treatments for this virus have been long, cumbersome, and laden with horrible side effects. The newest drug in our armamentarium, Sovaldi (sofosbuvir), offers the promise of substantially shortening treatment regimens while, at the same time, enhancing treatment response. In short, this is a wonder drug that we all should be grateful to scientists for developing and pharmaceutical companies for funding...(Read the full text of "The Price is Right: New Hepatitis C Drug is Really a Priceless Breakthrough".)
